Results

Total Results: 768 records

Showing results for "therapeutic".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
    August 11, 2014 - state in the Discussion chapter, Key Findings section for KQ2, “Furthermore, many RCTs that tested therapeutic … in patients with chronic kidney disease help to determine the relative effectiveness of specific therapies … The most disappointing part of the conclusions (no fault of the systematic review) is the lack of therapeutics … Should pharmacologists be a target despite the fact that there are no therapeutic trials that reduce … The point that measurement of these biomarkers does is not yet linked to additional specific therapies
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
    September 01, 2012 - o Does the use of the SFLC assay influence the type of treatment (e.g., radiation therapy)? … of treatment or use of adjunctive therapy or stem-cell transplantation) in patients with PCDs? … o Does the use of the SFLC assay influence the type of treatment (e.g., radiation therapy)? … of treatment or use of adjunctive therapy or stem-cell transplantation) in patients with PCDs? … Does the use of the SFLC assay influence the type of treatment (e.g., radiation therapy)?”
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research-protocol.pdf
    September 02, 2016 - registries and publications.8- 11 Despite efforts to spur pediatric research, children remain “therapeuticTherapeutic orphans. Pediatrics. 1999 Sep;104(3 Pt 2):583-4. PMID: 10469793. 13. … Clinical therapeutics. 2014 Feb 1;36(2):156-62. PMID: 24529287. 15. … effectiveness of tympanostomy tubes, compared to watchful waiting with episodic or prophylactic antibiotic therapy … Pathogens cultured from otorrhea • KQ 5 Treatment of otorrhea: o Final health or patient-centered
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
    December 11, 2012 - Many of these studies show survival benefit and therapeutic effectiveness. … to one another, but it is outside the scope of the report for the authors to comment on if these treatments … did these patients receive their treatment? … In my opinion, there should be more detail in the Tables with regards to previous treatments (i.e., … Since these treatments are available to them off trial, patients do not want to enroll in studies and
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery_research.pdf
    June 01, 2010 - Lipid-lowering therapies decreased by 55% and 52% among enrollees with and without diabetes, respectively … Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled … An operation proves to be the most effective therapy for adult- onset diabetes mellitus. … Medications HMG-CoA reductase inhibitor fibrates niacin bile acid sequestrant other lipid lowering therapies … Diabetes Treatments insulin pramlintide sulfonylureas biguanides thiazolidinedione alpha
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
    July 01, 2009 - , and assess long-term outcomes of treatments. … and assess long-term outcomes of treatments. … will be data elements that are essential to understanding the effectiveness or safety related to therapeutic …  Persistence with initial ODM therapies differed across specific monotherapy and combination therapy … Glycemic response to newly initiated diabetes therapies.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
    January 01, 2014 - developed a consensus definition of MTM as “a distinct service or group of services that optimize therapeutic … the CMR as “a systematic process of collecting patient-specific information, assessing medication therapies … designed to improve patients’ knowledge of their prescriptions, over-the-counter medications, herbal therapies … substitution issue; complex regimen that can be simplified with same therapeutic benefit; and potential … We will also consider conducting mixed-treatment comparisons in a meta-analysis using Bayesian methods
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-seniors-death_research.pdf
    August 01, 2007 - Results: 12,882 seniors initiated conventional APM therapy and 24,359 atypical APMs. … Clin Therapeutics 2002; 24(9): 1466- 76. 6 Health Canada. … J Am Stat Assoc 1983; 79: 516-524. 26 Braitman LE, Rosenbaum PR: Rare outcomes, common treatments … A review of uses of health care utilization databases for epidemiologic research on therapeutics. … 1.60 (1.42-1.80) 40-79 Days after beginning therapy 1.31 (1.14-1.51) 80-180 Days after beginning therapy
  9. Han (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/han.pdf
    December 26, 2012 - and representations of different sources of uncertainty in the example of outcomes of breast cancer treatment … • Probability: 20% probability of benefit from treatment (Indeterminacy of  future outcome) • … Ambiguity: o 10-­‐30%  probability of benefit from treatment (Imprecision) o Expert disagreement … about benefits of treatment o (Conflicting opinion/evidence) o Insufficient  scientific evidence … ) to predict  a diagnostic or therapeutic outcome
  10. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … with one or more standard therapies, including corticosteroids, immunomodulators, or tumor necrosis … unmet need for new therapeutic options for patients with IBS. … , alternative therapies are needed. … FDA approves two therapies to treat IBS-D. [internet]. Silver Spring (MD): U.S.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - , screening and diagnostics, therapeutics, surgery, and care delivery innovations—which are referred … Potential to change current treatment models ii. … The MarketScan Treatment Pathways data analytics tool was used to estimate costs of existing treatments … , and clinical, therapeutic, industry and socioeconomic issues X X X X X Cardiovascular Update … treatments.
  12. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - , screening and diagnostics, therapeutics, surgery, and care delivery innovations—which are referred … Potential to change current treatment models ii. … The MarketScan Treatment Pathways data analytics tool was used to estimate costs of existing treatments … , and clinical, therapeutic, industry and socioeconomic issues X X X X X Cardiovascular Update … treatments.
  13. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … (Contrave ® , Orexigen Therapeutics, Inc., La Jolla, CA in collaboration with Takeda Pharmaceutical … New drug treatment options are needed for obese patients seeking medical therapy for weight loss. … Goods Administration for inclusion in its therapeutic goods registry for treating T2DM and obesity
  14. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - therapeutic effects and better glycemic control. … therapeutic effects and better glycemic control. … Both anti- angiogenic and corticosteroid treatments require ongoing treatment involving multiple intravitreal … Hayward (CA): Intarcia Therapeutics, Inc.; 2009. 1 p. … Investigational therapeutic options in the management of DME: investigational pharmacologic treatments
  15. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … for patients whose conditions fail to respond to available medications and behavioral therapies for … Personalized drug therapy has traditionally lagged behind behavioral therapy in this regard because … Double-blind, placebo-controlled trial of ketamine therapy in treatment-resistant depression (TRD … Therapeutic options in treatment-resistant depression. Ann Med. 2011 Nov;43(7):512-30.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
    May 09, 2016 - Table A: Inclusion/Exclusion Criteria KQ1a(Pharmacologic treatments) KQ2a(Pharmacologic treatments) … KQ1b(Non-pharmacologic treatments) KQ2b(Non-pharmacologic For prevention of DPN Complications treatments … [tiab] OR therapies[tiab]) AND (moving[tiab] OR sports[tiab]))) OR “Stair Navigation”[tiab] OR postural … therapy”[tiab] OR “cognitive Psychotherapy”[tiab] OR “behavioral therapy”[tiab] OR “behavioral therapies … Xylocaine (Lidocaine) AstraZeneca Qutenza (Capsaicin) Acorda Therapeutics, Inc 20 !
  17. effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research
  18. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … cognitive behavior therapies. … efficacy for suicidal ideation and as an adjunct treatment to behavior and brain-stimulation therapies … added to existing therapies. … Therapeutic options in treatment-resistant depression. Ann Med. 2011 Nov;43(7):512-30.
  19. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
    January 01, 2016 - Many patients with T2DM do not meet treatment goals and require additional therapy with one of two … Some patients with T2DM also need insulin therapy, but most undergo treatment with pharmacotherapy … Other treatment options, such as anti-VEGF therapies are available for treating DME, and according … (e.g., anti-VEGF therapies). … Intarcia Therapeutics. A study to evaluate ITCA 650 for the treatment of type 2 diabetes.
  20. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-medical-update_research-protocol.pdf
    February 16, 2016 - b)   Is the effectiveness of the therapies reviewed affected by co-interventions or prior treatment … targeting sensory challenges as driving outcomes, either within a single treatment or across treatments … [sh]  OR  therapeutics[mh]  OR  teaching[mh]  OR  psychotherapy[mh]  OR   treatment  outcome[mh]   7275093 …   5   (treatment[tiab]  OR  therapy[tiab]  OR  intervention[tiab]  OR  “control  group”[tiab]     OR … "[Mesh])  OR  (  "drug  therapy"  [Subheading]  OR  "Medication   Therapy  Management"[Mesh]  )   2368930

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: